Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Gastric Cancer × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 6 Breast Neoplasms 6 Fallopian Tube Neoplasms 5 Neoplasms 4 Carcinoma, Ovarian Epithelial 3 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Prostate Cancer Metastatic 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration Resistant Prostate Cancer 1 Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1 Lung Neoplasms 1 Genital Neoplasms, Female 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1 Advanced Gastric Cancer 1 Adenocarcinoma of Lung 1

Interventions

Oxaliplatin 5 Capecitabine 4 Paclitaxel 3 Fluorouracil 3 Cisplatin 3 camrelizumab 2 apatinib 2 S 1 (combination) 2 Leucovorin 2 titanium silicide 1 rucaparib 1 relatlimab 1 pazopanib 1 linrodostat 1 ezogabine 1 endostar protein 1 dacomitinib 1 capivasertib 1 Sunitinib 1 Nivolumab 1 Metabolic Networks and Pathways 1 Irinotecan 1 Ipilimumab 1 Everolimus 1 Epirubicin 1 Electroporation 1 Drug Therapy, Combination 1 Drug Therapy 1 Docetaxel 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡